05 Sep Reducing adverse drug events by targeting at-risk patients
nowing which patients are most at-risk for adverse drug events would help hospitals direct pharmacist-led counseling services to those who need it the most. The American Society of Health-System Pharmacists (ASHP) Foundation is funding research it believes will make it easier to identify those patients.
The ASHP Foundation has awarded a two-year, $499,000 grant to University of Florida College of Pharmacy (UFCOP) researcher Almut Winterstein. He will lead a University of Florida Health research team that will develop a patient complexity score that will direct pharmacists to the patients who need MTM counseling the most.
“Adverse events in healthcare have received increasing attention over the past two decades because many are preventable,” said Winterstein, a professor of pharmaceutical outcomes and policy at the UFCOP. “Errors surrounding the selection or dosing of medications have been described as one of the most prominent areas in healthcare that result in preventable adverse events.”